Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-08-02FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2007-07-25FDA Approved: PAROXETINE — Original Application (NorthStar Rx LLC)
FDA approves NorthStar Rx LLC's original ANDA for paroxetine hydrochloride (generic paroxetine).
-
FDA approval · 2007-07-13FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for clomipramine hydrochloride submitted by SpecGx LLC.
-
FDA approval · 2007-07-09FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for fluvoxamine maleate (generic) submitted by Chartwell RX, LLC (ANDA 075900).
-
FDA approval · 2007-06-29FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clomipramine hydrochloride (Sun Pharmaceutical Industries), a drug used to treat obsessive-compu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-06-27FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for fluvoxamine maleate from Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2007-06-14Clinical Trial Update: Treatment for Anxiety in Children [Phase 3]
A Phase 3 clinical trial evaluating a treatment for anxiety disorders in children has completed. The study covered obsessive-compulsive diso…
-
FDA approval · 2007-05-24FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for fluoxetine, authorizing changes to the product's labeling.
-
CLINICAL_TRIALS trial_result · 2007-04-30Clinical Trial Update: An Open-Label Study Of Lamictal In Neurotic Excoriation [Phase 2]
An open-label Phase 2 study evaluating lamotrigine (Lamictal) for neurotic excoriation, with neurotic disorders and obsessive-compulsive dis…
-
FDA approval · 2007-04-30FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved ScieGen Pharmaceuticals Inc.'s sertraline hydrochloride as a generic under an Original Abbreviated New Drug Application for the…
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD) [Phase 4]
Phase 4 clinical trial evaluating escitalopram for obsessive-compulsive disorder has completed.
-
FDA approval · 2007-03-15FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2007-03-07FDA Approved: PAROXETINE — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences Limited's original application for paroxetine hydrochloride tablets (generic paroxetine). This approval prov…
-
FDA approval · 2007-02-09FDA Approved: FLUOXETINE — Original Application (Lannett Company, Inc.)
FDA approved the original application for a generic fluoxetine hydrochloride product from Lannett Company, Inc.
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' sertraline hydrochloride as a generic drug via an Original ANDA approval.
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA) for sertraline hydrochloride from Quallent Pharmaceuticals Health LLC, a generic version of sert…
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original application for a generic sertraline hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2007-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for paroxetine hydrochloride as a generic product. Paroxetine is used to treat maj…
-
FDA approval · 2007-01-25FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2006-11-17FDA Approved: FLUOXETINE — Supplemental Application (TIME CAP LABORATORIES, INC.)
The FDA approved a supplemental application for a fluoxetine hydrochloride product from Time Cap Laboratories, Inc., approving this generic …
-
FDA approval · 2006-10-18FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for fluvoxamine maleate from Chartwell RX, LLC, updating the generic product's approval.
-
FDA label_change · 2006-09-20FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company, approving changes to the …
-
FDA approval · 2006-08-22FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2006-08-22FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Paroxetine hydrochloride submitted by Apotex Corp.
-
FDA approval · 2006-08-11FDA Approved: SERTRALINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for sertraline (generic) by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals.